Ranbaxy says US appeals court should affirm judgment in Lipitor antitrust suit
MLex Summary: Ranbaxy asked a US appeals court to affirm a summary judgment against US antitrust claims over the drug Lipitor, saying plaintiffs can’t show standing. It argued that plaintiffs have...To view the full article, register now.
Already a subscriber? Click here to view full article